Literature DB >> 8431763

Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease.

R Endoh1, M Ogawara, T Iwatsubo, I Nakano, H Mori.   

Abstract

Using seven independent antibodies against the amino terminal to the carboxyl terminal sequence of tau, we biochemically analyzed and compared the neuropathogenesis of two Alzheimer's disease brains from the viewpoint of abnormal processing on tau, the major constituent of paired helical filaments. One showed typical Alzheimer's disease with senile plaques and intracellular neurofibrillary tangles. The other showed advanced Alzheimer's disease with senile plaques and virtually the sole of ghost tangles without intracellular neurofibrillary tangles. We confirmed the previous observation that the carboxyl thirds of tau are tightly associated with paired helical filaments isolated in the presence of SDS. We found that biochemically, ghost tangles were abnormally phosphorylated and lacked the final carboxyl terminal sequence as well as the amino half of tau, unlike intracellular tangles. From these biochemical results taken together with the current evidence for ubiquitin in ghost tangles, we concluded that ghost tangles were extensively processed and irreversibly transformed into highly insoluble extracellular deposits.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431763     DOI: 10.1016/0006-8993(93)91707-y

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.

Authors:  Patrick Reilly; Charisse N Winston; Kelsey R Baron; Margarita Trejo; Edward M Rockenstein; Johnny C Akers; Najla Kfoury; Marc Diamond; Eliezer Masliah; Robert A Rissman; Shauna H Yuan
Journal:  Neurobiol Dis       Date:  2017-06-10       Impact factor: 5.996

2.  Prion-like disorders: blurring the divide between transmissibility and infectivity.

Authors:  Mimi Cushman; Brian S Johnson; Oliver D King; Aaron D Gitler; James Shorter
Journal:  J Cell Sci       Date:  2010-04-15       Impact factor: 5.285

3.  Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation.

Authors:  T Miyasaka; M Morishima-Kawashima; R Ravid; P Heutink; J C van Swieten; K Nagashima; Y Ihara
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 4.  Probing modifications of the neuronal cytoskeleton.

Authors:  L C Doering
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

5.  Monitoring pathological assembly of tau and beta-amyloid proteins in Alzheimer's disease.

Authors:  R Mena; P Edwards; O Pérez-Olvera; C M Wischik
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 6.  The expanding realm of prion phenomena in neurodegenerative disease.

Authors:  Bess Frost; Marc I Diamond
Journal:  Prion       Date:  2009-04-16       Impact factor: 3.931

7.  Propagation of tau misfolding from the outside to the inside of a cell.

Authors:  Bess Frost; Rachel L Jacks; Marc I Diamond
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

8.  Motor neuron disease with dementia and ophthalmoplegia. A clinical and pathological study.

Authors:  H Komachi; R Okeda; N Ishii; K Yanagisawa; M Yamada; T Miyatake
Journal:  J Neurol       Date:  1994-10       Impact factor: 4.849

9.  Spastic tetraplegia as an initial manifestation of familial Alzheimer's disease.

Authors:  N Sodeyama; M Shimada; T Uchihara; K Yanagisawa; H Fujigasaki; K Yamaguchi; M Matsushita; M Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

10.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

Authors:  E Braak; H Braak; E M Mandelkow
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.